CervoMed Inc.CRVONASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+110.2%
5Y CAGR+15.3%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+110.2%/yr
vs -26.5%/yr prior
5Y CAGR
+15.3%/yr
Recent acceleration
Acceleration
+136.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$32.30M+77.2%
2024$18.23M+133.3%
2023$7.81M+124.8%
2022$3.48M-85.9%
2021$24.68M+55.5%
2020$15.87M+38.6%
2019$11.45M-3.9%
2018$11.92M+5.7%
2017$11.28M-24.0%
2016$14.85M-